Immune response drives outcomes in prostate cancer: implications for immunotherapy

The heterogeneity of the immune microenvironment leads to different responses in immune checkpoint blockade therapy. We aimed to propose a robust molecular classification system to investigate the relevance of the immune microenvironment subtype and prognosis of prostate cancer patients, as well as...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Jialin, Zhou, Yujie, Lu, Xiaofan, Bian, Zichen, Chen, Yiding, Zhou, Jun, Zhang, Li, Hao, Zongyao, Zhang, Meng, Liang, Chaozhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096785/
https://www.ncbi.nlm.nih.gov/pubmed/33338321
http://dx.doi.org/10.1002/1878-0261.12887

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096785/
https://www.ncbi.nlm.nih.gov/pubmed/33338321
http://dx.doi.org/10.1002/1878-0261.12887

Ejemplares similares